MTOR and cancer: Everolimus (RAD001) is an mTORC1 inhibitor that reduces cancer cell proliferation and induces apoptosis by inhibiting mTOR, thereby reversing trastuzumab resistance caused by the overactivation of the PAM pathway due to PTEN loss.